Rite Aid Corporation has announced the successful completion of the sale of its Elixir Solutions business to MedImpact Healthcare Systems, Inc. The transaction, valued at approximately $575 million, is part of Rite Aid’s strategy to focus on its core healthcare products and services. Rite Aid’s CEO, Jeffrey S. Stein, expressed satisfaction with the outcome and believes that the divestiture will position Rite Aid for long-term success. The company remains committed to delivering leading healthcare products and services as it progresses through its restructuring process. Rite Aid’s legal counsel for the transaction was Kirkland & Ellis LLP, with Guggenheim Securities serving as the investment banker and Alvarez & Marsal as the transformation officer and financial advisor.
Rite Aid Completes $575M Sale of Elixir Solutions Business to MedImpact
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
